• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

除了胆甾醇以外,升高的胆固醇前体也可以作为 CTX 的特征。

Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX.

机构信息

Department of Metabolic and Endocrine Diseases, University Medical Centre Utrecht, HP KC 02.069.1, Lundlaan 6 3584 CX, Utrecht, The Netherlands.

出版信息

J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S387-93. doi: 10.1007/s10545-008-0963-1. Epub 2008 Oct 24.

DOI:10.1007/s10545-008-0963-1
PMID:18949577
Abstract

Cerebrotendinous xanthomatosis (CTX) is an inborn error of bile acid synthesis in which hepatic conversion of cholesterol to cholic and chenodeoxycholic acids is impaired. Patients have abnormal bile alcohols in urine, normal to increased plasma cholesterol concentrations and increased concentrations of plasma cholestanol. Little is known about cholesterol precursors in CTX, however. We studied cholesterol and phytosterol profiles in two siblings with CTX during follow-up. While cholesterol concentrations were low in both patients, plasma cholestanol was 6-fold higher compared to control values. In addition, both siblings had a more than 100-fold increase in 7-dehydrocholesterol (7DHC) and 8-dehydrocholesterol (8DHC). Lathosterol, lanosterol and sitosterol were increased in both patients while concentrations of desmosterol and campesterol were normal. In addition, plasma lathosterol/cholesterol ratios were significantly elevated. After treatment with chenodeoxycholate, both patients showed a marked decrease in cholestanol, 7DHC, 8DHC, lathosterol, lanosterol and sitosterol. In addition, the lathosterol/cholesterol ratio normalized, indicating that overall cholesterol synthesis was sufficiently suppressed. This study shows that elevated cholesterol precursors, other than cholestanol, can be a hallmark for CTX.

摘要

脑腱黄瘤病(CTX)是一种先天性胆汁酸合成错误,肝脏将胆固醇转化为胆酸和鹅脱氧胆酸的能力受损。患者尿液中存在异常的胆汁醇,血浆胆固醇浓度正常或升高,且血浆胆甾烷醇浓度升高。然而,关于 CTX 中的胆固醇前体知之甚少。我们在 CTX 患者的随访过程中研究了两个同胞的胆固醇和植物甾醇谱。虽然两个患者的胆固醇浓度均较低,但血浆胆甾烷醇比对照值高 6 倍。此外,两个患者的 7-脱氢胆固醇(7DHC)和 8-脱氢胆固醇(8DHC)均增加了 100 多倍。两个患者的羊毛甾醇、菜油甾醇和谷甾醇均升高,而粪甾醇和菜油甾醇的浓度正常。此外,血浆羊毛甾醇/胆固醇比值显著升高。在用鹅脱氧胆酸治疗后,两个患者的胆甾烷醇、7DHC、8DHC、羊毛甾醇、菜油甾醇和谷甾醇均显著降低。此外,羊毛甾醇/胆固醇比值正常化,表明总胆固醇合成得到充分抑制。这项研究表明,升高的胆固醇前体,除胆甾烷醇外,也可能是 CTX 的一个特征。

相似文献

1
Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX.除了胆甾醇以外,升高的胆固醇前体也可以作为 CTX 的特征。
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S387-93. doi: 10.1007/s10545-008-0963-1. Epub 2008 Oct 24.
2
Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.脑腱黄瘤病患者胆固醇合成中间体的同位素异构体光谱分析。
Metabolism. 2005 Mar;54(3):335-44. doi: 10.1016/j.metabol.2004.09.013.
3
High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.脑腱黄瘤病中植物甾醇和胆固醇前体水平升高。
J Lipid Res. 1991 Feb;32(2):223-9.
4
Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis.亲水性7β-羟基胆汁酸、洛伐他汀和考来烯胺对 cerebrotendinous 黄瘤病的治疗无效。
Metabolism. 2004 May;53(5):556-62. doi: 10.1016/j.metabol.2003.12.003.
5
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.基因和临床确诊的非典型脑腱黄瘤病,伴有正常胆甾烷醇和胆汁酸前体及胆汁醇显著升高。
J Clin Lipidol. 2024 May-Jun;18(3):e465-e476. doi: 10.1016/j.jacl.2024.03.004. Epub 2024 Mar 15.
6
Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?类固醇会掩盖脑腱性黄瘤病的诊断吗?
J Neurol Sci. 2006 Apr 15;243(1-2):83-6. doi: 10.1016/j.jns.2005.10.019. Epub 2006 Jan 30.
7
Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults.胆酸治疗成人脑腱黄瘤病。
J Neurol. 2019 Aug;266(8):2043-2050. doi: 10.1007/s00415-019-09377-y. Epub 2019 May 21.
8
Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study.胆固醇和羊毛固醇血浆浓度的年龄相关性变化:一项探索性研究。
Lipids Health Dis. 2019 Dec 30;18(1):235. doi: 10.1186/s12944-019-1176-3.
9
Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.脑腱黄瘤病中胆固醇代谢的评估
J Inherit Metab Dis. 2016 Jan;39(1):75-83. doi: 10.1007/s10545-015-9873-1. Epub 2015 Jul 8.
10
Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.脑腱性黄瘤病的治疗:鹅去氧胆酸、普伐他汀及联合使用的效果
J Neurol Sci. 1994 Aug;125(1):22-8. doi: 10.1016/0022-510x(94)90237-2.

引用本文的文献

1
Cerebrotendinous xanthomatosis: a literature review and case study.脑腱性黄瘤病:文献综述与病例研究
Front Cardiovasc Med. 2024 Dec 9;11:1496442. doi: 10.3389/fcvm.2024.1496442. eCollection 2024.
2
A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous xanthomatosis and Smith-Lemli-Opitz syndrome.用于罕见脂质紊乱的固醇检测项目:谷甾醇血症、脑腱黄瘤病和史密斯-莱姆利-奥皮茨综合征。
J Lipid Res. 2025 Jan;66(1):100698. doi: 10.1016/j.jlr.2024.100698. Epub 2024 Nov 19.
3
The 20-Year Diagnostic Odyssey of a Milder Form of Cerebrotendinous Xanthomatosis.

本文引用的文献

1
Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation.肝移植前后,作为原发性胆汁性肝硬化肝功能标志物的甾醇参数
Transpl Int. 2005 Feb;18(2):221-5. doi: 10.1111/j.1432-2277.2004.00002.x.
2
Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.美国家系中脑腱性黄瘤病的精细定位、突变分析及结构定位
J Lipid Res. 2001 Feb;42(2):159-69.
3
Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping.
一种较轻型脑腱黄瘤病的20年诊断历程
JCEM Case Rep. 2024 Jan 19;2(2):luae004. doi: 10.1210/jcemcr/luae004. eCollection 2024 Feb.
4
Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.脑腱黄瘤病脂质异常的病理生理学与治疗:一项综合综述
Brain Sci. 2023 Jun 22;13(7):979. doi: 10.3390/brainsci13070979.
5
Cerebrotendinous Xanthomatosis: A practice review of pathophysiology, diagnosis, and treatment.脑腱黄瘤病:病理生理学、诊断及治疗的实践综述
Front Neurol. 2022 Dec 23;13:1049850. doi: 10.3389/fneur.2022.1049850. eCollection 2022.
6
Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.缺乏典型生化表现的脑腱黄瘤病的家族变异性
JIMD Rep. 2021 Jan 8;59(1):3-9. doi: 10.1002/jmd2.12197. eCollection 2021 May.
7
Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.经基因检测确诊的脑腱黄瘤病中国患者:病例报告及文献综述
World J Clin Cases. 2020 Nov 6;8(21):5446-5456. doi: 10.12998/wjcc.v8.i21.5446.
8
Misdiagnosis of CTX due to propofol: The interference of total intravenous propofol anaesthesia with bile acid profiling.因丙泊酚导致 CTX 的误诊:全静脉注射丙泊酚麻醉对胆汁酸谱分析的干扰。
J Inherit Metab Dis. 2020 Jul;43(4):843-851. doi: 10.1002/jimd.12219. Epub 2020 Feb 7.
9
Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study.胆固醇和羊毛固醇血浆浓度的年龄相关性变化:一项探索性研究。
Lipids Health Dis. 2019 Dec 30;18(1):235. doi: 10.1186/s12944-019-1176-3.
10
Autism spectrum disorder: an early and frequent feature in cerebrotendinous xanthomatosis.脑腱黄瘤病:早发且常见于孤独症谱系障碍。
J Inherit Metab Dis. 2018 Jul;41(4):641-646. doi: 10.1007/s10545-017-0086-7. Epub 2017 Sep 11.
16例RSH/史密斯-勒米-奥皮茨综合征患者的突变分析与描述:基于聚合酶链反应的检测方法以简化基因分型
Am J Med Genet. 2000 Sep 18;94(3):214-27.
4
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis.脑腱黄瘤病患者的临床和分子遗传学特征
Brain. 2000 May;123 ( Pt 5):908-19. doi: 10.1093/brain/123.5.908.
5
Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.辛伐他汀联合鹅去氧胆酸对脑腱黄瘤病患者的疗效
Metabolism. 1999 Feb;48(2):233-8. doi: 10.1016/s0026-0495(99)90040-9.
6
Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects.在血脂正常的受试者中,抑制胆固醇生成可减少载脂蛋白B-100的肝脏分泌。
Am J Physiol. 1997 Sep;273(3 Pt 1):E462-70. doi: 10.1152/ajpendo.1997.273.3.E462.
7
Cerebrotendinous xanthomatosis: molecular diagnosis enables presymptomatic detection of a treatable disease.脑腱黄瘤病:分子诊断可实现对可治疗疾病的症状前检测。
Neurology. 1994 Feb;44(2):288-90. doi: 10.1212/wnl.44.2.288.
8
Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis.洛伐他汀与鹅去氧胆酸对脑腱黄瘤病患者血浆胆甾烷醇水平及胆汁酸代谢异常的比较效果
Metabolism. 1994 Aug;43(8):1018-22. doi: 10.1016/0026-0495(94)90183-x.
9
Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.脑腱性黄瘤病的治疗:鹅去氧胆酸、普伐他汀及联合使用的效果
J Neurol Sci. 1994 Aug;125(1):22-8. doi: 10.1016/0022-510x(94)90237-2.
10
Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family.法国一家族中,胆固醇27-羟化酶基因的过早终止密码子导致脑腱性黄瘤病。
Hum Genet. 1995 Feb;95(2):238-40. doi: 10.1007/BF00209413.